Rabies and envenomings [[electronic resource] ] : a neglected public health issue : report of a consultative meeting, World Health Organization, Geneva, 10 January 2007 / / [prepared by D. Warrell and J-M Gutiérrez] |
Autore | Warrell D. A |
Pubbl/distr/stampa | Geneva, : World Health Organization, 2007 |
Descrizione fisica | 1 online resource (38 p.) |
Altri autori (Persone) | GutiérrezJ-M (José María) |
Soggetto topico |
Rabies - Patients - Medical care
Rabies - Epidemiology Rabies - Chemotherapy Bites and stings - Patients - Medical care Bites and stings - Epidemiology Bites and stings - Chemotherapy Immune serums - Therapeutic use Drug utilization Poisonous animals - Venom - Physiological effect |
Soggetto genere / forma | Electronic books. |
ISBN | 92-4-068290-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910454743503321 |
Warrell D. A
![]() |
||
Geneva, : World Health Organization, 2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Rabies and envenomings [[electronic resource] ] : a neglected public health issue : report of a consultative meeting, World Health Organization, Geneva, 10 January 2007 / / [prepared by D. Warrell and J-M Gutiérrez] |
Autore | Warrell D. A |
Pubbl/distr/stampa | Geneva, : World Health Organization, 2007 |
Descrizione fisica | 1 online resource (38 p.) |
Altri autori (Persone) | GutiérrezJ-M (José María) |
Soggetto topico |
Rabies - Patients - Medical care
Rabies - Epidemiology Rabies - Chemotherapy Bites and stings - Patients - Medical care Bites and stings - Epidemiology Bites and stings - Chemotherapy Immune serums - Therapeutic use Drug utilization Poisonous animals - Venom - Physiological effect |
ISBN | 92-4-068290-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910782410703321 |
Warrell D. A
![]() |
||
Geneva, : World Health Organization, 2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Rabies and envenomings [[electronic resource] ] : a neglected public health issue : report of a consultative meeting, World Health Organization, Geneva, 10 January 2007 / / [prepared by D. Warrell and J-M Gutiérrez] |
Autore | Warrell D. A |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Geneva, : World Health Organization, 2007 |
Descrizione fisica | 1 online resource (38 p.) |
Disciplina | 614.563 |
Altri autori (Persone) | GutiérrezJ-M (José María) |
Soggetto topico |
Rabies - Patients - Medical care
Rabies - Epidemiology Rabies - Chemotherapy Bites and stings - Patients - Medical care Bites and stings - Epidemiology Bites and stings - Chemotherapy Immune serums - Therapeutic use Drug utilization Poisonous animals - Venom - Physiological effect |
ISBN | 92-4-068290-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Intro -- CONTENTS -- SUMMARY -- INTRODUCTION -- Chapter 1 RABIES AND ENVENOMINGS: neglected diseases -- Chapter 2 EPIDEMIOLOGY: the burden of disease RABIES -- Chapter 3 PRODUCTION AND CONTROL OF THERAPEUTIC ANTISERA -- Chapter 4 DISTRIBUTION AND APPROPRIATE USE OF THERAPEUTIC ANTISERA: failure to supply those at greatest need -- Chapter 5 SCALES OF PRODUCTION: the need to strengthen capacity -- Chapter 6 PREQUALIFICATION OF ANTISERA: the way to improve access to quality and safe products -- Chapter 7 TOWARDS A GLOBAL SOLUTION: a WHO initiative to improve availability of safe antisera -- REFERENCES -- LIST OF PARTICIPANTS. |
Record Nr. | UNINA-9910822375903321 |
Warrell D. A
![]() |
||
Geneva, : World Health Organization, 2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Screening for drug use in general medical settings [[electronic resource] ] : quick reference guide |
Pubbl/distr/stampa | [Rockville, Md.] : , : National Institute on Drug Abuse, , [2009] |
Descrizione fisica | 1 online resource (9 unnumbered pages) : color illustrations |
Collana | NIH publication |
Soggetto topico |
Drug utilization
Drinking of alcoholic beverages Patients - Drug use Patients - Alcohol use Clinics Health risk assessment |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Screening for drug use in general medical settings |
Record Nr. | UNINA-9910699524703321 |
[Rockville, Md.] : , : National Institute on Drug Abuse, , [2009] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The selection and use of essential medicines : report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children) / / World Health Organization |
Pubbl/distr/stampa | Geneva, Switzerland : , : World Health Organization, , 2014 |
Descrizione fisica | 1 online resource (235 p.) |
Disciplina | 615.58 |
Collana | WHO Technical Report Series |
Soggetto topico | Drug utilization |
Soggetto genere / forma | Electronic books. |
ISBN | 92-4-069225-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Contents; Executive summary; List of participants; Declarations of interests; 1. Introduction; 2. Open session; 3. General items; 3.1 Defining public health relevance; 3.2 Medicines information as a global public good; 3.3 Other; 4. Applications only for paediatric medicines; Section 1: Anaesthetics; Anaesthetics (review) - Children; Section 2: Non-steroidal anti-inflammatory medicines (NSAIMs) and medicines used to treat gout and disease-modifying agents in rheumatoid disorders (DMARDs); 2.2: Opioid analgesics; Section 6: Anti-infective medicines; 6.2: Antibacterials
6.4: Antiviral medicines6.5: Antiprotozoal medicines; Section 8: Antineoplastics; 8.4: Medicines used in palliative care; Section 11: Blood products and plasma substitutes; 11.1: Plasma substitutes; Section 12: Cardiovascular medicines; 12.2: Antiarrhythmic medicines; 12.6: Lipid-lowering agents; Section 15: Disinfectants and antiseptics; 15.1: Antiseptics; Section 24: Medicines for mental and behavioural disorders; 24.1: Medicines used in psychotic disorders; 24.2: Medicines used in mood disorders; Section 28: Ear, nose and throat medicines; Section 29: Specific medicines for neonatal care 5. Applications for the 18th Model List and the 4th EMLcSection 2: NSAIMs and DMARDs; 2.1: Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs); 2.3: Medicines used to treat gout; Section 3: Antiallergics and medicines used in anaphylaxis; Section 4: Antidotes and other substances used in poisonings; Section 6: Anti-infective medicines; 6.2: Antibacterials; 6.3: Antifungal medicines; 6.4: Antiviral medicines; 6.5: Antiprotozoal medicines; Section 8: Antineoplastics, immunosuppressives and medicines used in palliative care; 8.2: Cytotoxic and adjuvant medicines 8.4: Medicines used in palliative careSection 9: Antiparkinsonism medicines; Section 10: Medicines affecting the blood; 10.1: Antianaemia medicines; Section 11: Blood products and plasma substitutes; 11.2: Plasma fractions for specific use; Section 12: Cardiovascular medicines; 12.4: Medicines used in heart failure; Section 13: Dermatological medicines (topical); 13.4: Medicines affecting skin differentiation and proliferation; Section 17: Gastrointestinal medicines; 17.1: Antiulcer medicines; Section 18: Hormones, other endocrine medicines and contraceptives 18.5: Insulins and other medicines used for diabetesSection 21: Ophthalmological preparations; Section 22: Oxytocics and antioxytocics; 22.1: Oxytocics; Section 24: Medicines for mental and behavioural disorders; 24.1: Medicines used in psychotic disorders; 24.2: Medicines used in mood disorders; Section 27: Vitamins and minerals; Section 28: Ear, nose and throat medicines; 6. Summary of recommendations; 18th WHO Model List of Essential Medicines; 4th Essential Medicines List for Children; Recommendations for reviews; References; Annex 1 18th WHO Model List of Essential Medicines (April 2013) Annex 2 4th WHO Model List of Essential Medicines for Children (April 2013) |
Record Nr. | UNINA-9910464527303321 |
Geneva, Switzerland : , : World Health Organization, , 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The selection and use of essential medicines : report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children) / / World Health Organization |
Pubbl/distr/stampa | Geneva, Switzerland : , : World Health Organization, , 2014 |
Descrizione fisica | 1 online resource (235 p.) |
Disciplina | 615.58 |
Collana | WHO Technical Report Series |
Soggetto topico | Drug utilization |
ISBN | 92-4-069225-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Contents; Executive summary; List of participants; Declarations of interests; 1. Introduction; 2. Open session; 3. General items; 3.1 Defining public health relevance; 3.2 Medicines information as a global public good; 3.3 Other; 4. Applications only for paediatric medicines; Section 1: Anaesthetics; Anaesthetics (review) - Children; Section 2: Non-steroidal anti-inflammatory medicines (NSAIMs) and medicines used to treat gout and disease-modifying agents in rheumatoid disorders (DMARDs); 2.2: Opioid analgesics; Section 6: Anti-infective medicines; 6.2: Antibacterials
6.4: Antiviral medicines6.5: Antiprotozoal medicines; Section 8: Antineoplastics; 8.4: Medicines used in palliative care; Section 11: Blood products and plasma substitutes; 11.1: Plasma substitutes; Section 12: Cardiovascular medicines; 12.2: Antiarrhythmic medicines; 12.6: Lipid-lowering agents; Section 15: Disinfectants and antiseptics; 15.1: Antiseptics; Section 24: Medicines for mental and behavioural disorders; 24.1: Medicines used in psychotic disorders; 24.2: Medicines used in mood disorders; Section 28: Ear, nose and throat medicines; Section 29: Specific medicines for neonatal care 5. Applications for the 18th Model List and the 4th EMLcSection 2: NSAIMs and DMARDs; 2.1: Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs); 2.3: Medicines used to treat gout; Section 3: Antiallergics and medicines used in anaphylaxis; Section 4: Antidotes and other substances used in poisonings; Section 6: Anti-infective medicines; 6.2: Antibacterials; 6.3: Antifungal medicines; 6.4: Antiviral medicines; 6.5: Antiprotozoal medicines; Section 8: Antineoplastics, immunosuppressives and medicines used in palliative care; 8.2: Cytotoxic and adjuvant medicines 8.4: Medicines used in palliative careSection 9: Antiparkinsonism medicines; Section 10: Medicines affecting the blood; 10.1: Antianaemia medicines; Section 11: Blood products and plasma substitutes; 11.2: Plasma fractions for specific use; Section 12: Cardiovascular medicines; 12.4: Medicines used in heart failure; Section 13: Dermatological medicines (topical); 13.4: Medicines affecting skin differentiation and proliferation; Section 17: Gastrointestinal medicines; 17.1: Antiulcer medicines; Section 18: Hormones, other endocrine medicines and contraceptives 18.5: Insulins and other medicines used for diabetesSection 21: Ophthalmological preparations; Section 22: Oxytocics and antioxytocics; 22.1: Oxytocics; Section 24: Medicines for mental and behavioural disorders; 24.1: Medicines used in psychotic disorders; 24.2: Medicines used in mood disorders; Section 27: Vitamins and minerals; Section 28: Ear, nose and throat medicines; 6. Summary of recommendations; 18th WHO Model List of Essential Medicines; 4th Essential Medicines List for Children; Recommendations for reviews; References; Annex 1 18th WHO Model List of Essential Medicines (April 2013) Annex 2 4th WHO Model List of Essential Medicines for Children (April 2013) |
Record Nr. | UNINA-9910786620103321 |
Geneva, Switzerland : , : World Health Organization, , 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The selection and use of essential medicines : report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children) / / World Health Organization |
Pubbl/distr/stampa | Geneva, Switzerland : , : World Health Organization, , 2014 |
Descrizione fisica | 1 online resource (235 p.) |
Disciplina | 615.58 |
Collana | WHO Technical Report Series |
Soggetto topico | Drug utilization |
ISBN | 92-4-069225-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Contents; Executive summary; List of participants; Declarations of interests; 1. Introduction; 2. Open session; 3. General items; 3.1 Defining public health relevance; 3.2 Medicines information as a global public good; 3.3 Other; 4. Applications only for paediatric medicines; Section 1: Anaesthetics; Anaesthetics (review) - Children; Section 2: Non-steroidal anti-inflammatory medicines (NSAIMs) and medicines used to treat gout and disease-modifying agents in rheumatoid disorders (DMARDs); 2.2: Opioid analgesics; Section 6: Anti-infective medicines; 6.2: Antibacterials
6.4: Antiviral medicines6.5: Antiprotozoal medicines; Section 8: Antineoplastics; 8.4: Medicines used in palliative care; Section 11: Blood products and plasma substitutes; 11.1: Plasma substitutes; Section 12: Cardiovascular medicines; 12.2: Antiarrhythmic medicines; 12.6: Lipid-lowering agents; Section 15: Disinfectants and antiseptics; 15.1: Antiseptics; Section 24: Medicines for mental and behavioural disorders; 24.1: Medicines used in psychotic disorders; 24.2: Medicines used in mood disorders; Section 28: Ear, nose and throat medicines; Section 29: Specific medicines for neonatal care 5. Applications for the 18th Model List and the 4th EMLcSection 2: NSAIMs and DMARDs; 2.1: Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs); 2.3: Medicines used to treat gout; Section 3: Antiallergics and medicines used in anaphylaxis; Section 4: Antidotes and other substances used in poisonings; Section 6: Anti-infective medicines; 6.2: Antibacterials; 6.3: Antifungal medicines; 6.4: Antiviral medicines; 6.5: Antiprotozoal medicines; Section 8: Antineoplastics, immunosuppressives and medicines used in palliative care; 8.2: Cytotoxic and adjuvant medicines 8.4: Medicines used in palliative careSection 9: Antiparkinsonism medicines; Section 10: Medicines affecting the blood; 10.1: Antianaemia medicines; Section 11: Blood products and plasma substitutes; 11.2: Plasma fractions for specific use; Section 12: Cardiovascular medicines; 12.4: Medicines used in heart failure; Section 13: Dermatological medicines (topical); 13.4: Medicines affecting skin differentiation and proliferation; Section 17: Gastrointestinal medicines; 17.1: Antiulcer medicines; Section 18: Hormones, other endocrine medicines and contraceptives 18.5: Insulins and other medicines used for diabetesSection 21: Ophthalmological preparations; Section 22: Oxytocics and antioxytocics; 22.1: Oxytocics; Section 24: Medicines for mental and behavioural disorders; 24.1: Medicines used in psychotic disorders; 24.2: Medicines used in mood disorders; Section 27: Vitamins and minerals; Section 28: Ear, nose and throat medicines; 6. Summary of recommendations; 18th WHO Model List of Essential Medicines; 4th Essential Medicines List for Children; Recommendations for reviews; References; Annex 1 18th WHO Model List of Essential Medicines (April 2013) Annex 2 4th WHO Model List of Essential Medicines for Children (April 2013) |
Record Nr. | UNINA-9910811249003321 |
Geneva, Switzerland : , : World Health Organization, , 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
The use of essential drugs : report of a WHO expert committee |
Pubbl/distr/stampa | Geneva, : World Health Organization, 1983- |
Descrizione fisica | 1 online resource |
Collana | Technical report series / World Health Organization |
Soggetto topico |
Drugs - Prescribing
Drug utilization Pharmaceutical services - Developing countries Drug Utilization Drugs, Essential Pharmaceutical services |
ISSN | 1996-9139 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996207844303316 |
Geneva, : World Health Organization, 1983- | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
The use of essential drugs : report of a WHO expert committee |
Pubbl/distr/stampa | Geneva, : World Health Organization, 1983- |
Descrizione fisica | 1 online resource |
Collana | Technical report series / World Health Organization |
Soggetto topico |
Drugs - Prescribing
Drug utilization Pharmaceutical services - Developing countries Drug Utilization Drugs, Essential Pharmaceutical services |
ISSN | 1996-9139 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910142426703321 |
Geneva, : World Health Organization, 1983- | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|